CORRECTION article

Front. Oncol., 14 July 2020

Sec. Molecular and Cellular Oncology

Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.01106

Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer

  • ST

    Shiming Tan 1

  • PY

    Pin Yi 1,2

  • HW

    Heran Wang 1,3

  • LX

    Longzheng Xia 1

  • YH

    Yaqian Han 1

  • HW

    Hui Wang 1

  • BZ

    Biao Zeng 1

  • LT

    Lu Tang 1,2

  • QP

    Qing Pan 1,2

  • YT

    Yutong Tian 1,2

  • SR

    Shan Rao 1

  • LO

    Linda Oyang 1

  • JL

    Jiaxin Liang 1

  • JL

    Jinguan Lin 1

  • MS

    Min Su 1

  • YS

    Yingrui Shi 1

  • QL

    Qianjin Liao 1*

  • YZ

    Yujuan Zhou 1*

  • 1. Hunan Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China

  • 2. Hunan Cancer Hospital, University of South China, Hengyang, China

  • 3. Hepatology Unit, Department of Infectious Disease, Nanfang Hospital, Southern Medical University, Guangzhou, China

The authors regret that there was an error in Figure 6 due to incorrect image editing in Figure 6C. The correct Figure 6 appears below.

FIGURE 6

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

RAC1, lung cancer, radioresistance, epithelial-to-mesenchymal transition, metastasis

Citation

Tan S, Yi P, Wang H, Xia L, Han Y, Wang H, Zeng B, Tang L, Pan Q, Tian Y, Rao S, Oyang L, Liang J, Lin J, Su M, Shi Y, Liao Q and Zhou Y (2020) Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer. Front. Oncol. 10:1106. doi: 10.3389/fonc.2020.01106

Received

26 May 2020

Accepted

02 June 2020

Published

14 July 2020

Volume

10 - 2020

Edited and reviewed by

Boris Zhivotovsky, Karolinska Institutet (KI), Sweden

Updates

Copyright

*Correspondence: Qianjin Liao Yujuan Zhou

This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics